Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective and Retrospective Data Collection Study to Evaluate Outcomes in Males ≤17 Years of Age Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Cerebral Adrenoleukodystrophy

NCT02204904 is registered in ClinicalTrials.gov with Genetix Biotherapeutics Inc. as lead sponsor.

NCT NCT02204904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02204904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective and Retrospective Data Collection Study to Evaluate Outcomes in Males ≤17 Years of Age Undergoing Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of Cerebral Adrenoleukodystrophy
Lead sponsor
Genetix Biotherapeutics Inc.
Phase
Observational
Overall status
Terminated
Start date
April 30, 2015
Completion date
December 6, 2019
Enrollment
59 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

adrenoleukodystrophy (ald), cerebral adrenoleukodystrophy (cald), x-linked adrenoleukodystrophy (x-ald)